The inhibitory mechanisms of PKA and/or CaMKII via TRPV1 are unclear, but previous studies have reported a cardioprotective role for TRPV1 in myocardial ischemia and reperfusion injury [9, 10]. This evidence concerns the gene CAMK2G and myocardial ischemia.